Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma

Published:2014-07-16 Issue:10 Volume:35 Page:2331-2338
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Gauglhofer Christine,Paur Jakob,Schrottmaier Waltraud C.,Wingelhofer Bettina,Huber Daniela,Naegelen Isabelle,Pirker Christine,Mohr Thomas,Heinzle Christine,Holzmann Klaus,Marian Brigitte,Schulte-Hermann Rolf,Berger Walter,Krupitza Georg,Grusch Michael,Grasl-Kraupp Bettina

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/35/10/2331/14132476/bgu151.pdf

Reference36 articles.

1. Hepatocellular carcinoma;Forner;Lancet,(2012)

2. Hepatocellular carcinoma (HCC): a global perspective. World Gastroenterology Organization;Ferenci;J. Clin. Gastroenterol.,(2010)

3. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies;Marquardt;J. Hepatol.,(2012)

4. Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison;Calvisi;Biochim. Biophys. Acta,(2012)

5. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis;Gauglhofer;Hepatology,(2011)

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer;European Journal of Medicinal Chemistry;2024-11

2. Signaling pathways in liver cancer: pathogenesis and targeted therapy;Molecular Biomedicine;2024-05-31

3. Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment;Biomedicines;2023-09-27

4. Benzimidazole‐based protein kinase inhibitors: Current perspectives in targeted cancer therapy;Chemical Biology & Drug Design;2022-08-19

5. Design, Synthesis, and Biological Evaluation of 2-Formyl Tetrahydronaphthyridine Urea Derivatives as New Selective Covalently Reversible FGFR4 Inhibitors;Journal of Medicinal Chemistry;2022-02-04